Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR

21.66  -0.3 (-1.37%)

Fundamental Rating

3

Overall ICAD gets a fundamental rating of 3 out of 10. We evaluated ICAD against 40 industry peers in the Diversified REITs industry. ICAD has a bad profitability rating. Also its financial health evaluation is rather negative. ICAD is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
In the past year ICAD had a positive cash flow from operations.
In multiple years ICAD reported negative net income over the last 5 years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

ICAD's Return On Assets of -2.62% is on the low side compared to the rest of the industry. ICAD is outperformed by 85.00% of its industry peers.
ICAD's Return On Equity of -6.38% is on the low side compared to the rest of the industry. ICAD is outperformed by 87.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.77%, ICAD is doing worse than 82.50% of the companies in the same industry.
ICAD had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.63%.
Industry RankSector Rank
ROA -2.62%
ROE -6.38%
ROIC 1.77%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

ICAD's Operating Margin of 13.47% is on the low side compared to the rest of the industry. ICAD is outperformed by 87.50% of its industry peers.
In the last couple of years the Operating Margin of ICAD has declined.
The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 13.47%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICAD is destroying value.
Compared to 1 year ago, ICAD has about the same amount of shares outstanding.
The number of shares outstanding for ICAD has been increased compared to 5 years ago.
The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that ICAD is in the distress zone and has some risk of bankruptcy.
ICAD has a Altman-Z score (0.83) which is comparable to the rest of the industry.
The Debt to FCF ratio of ICAD is 28.49, which is on the high side as it means it would take ICAD, 28.49 years of fcf income to pay off all of its debts.
ICAD has a worse Debt to FCF ratio (28.49) than 75.00% of its industry peers.
ICAD has a Debt/Equity ratio of 0.99. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
ICAD's Debt to Equity ratio of 0.99 is on the low side compared to the rest of the industry. ICAD is outperformed by 77.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Altman-Z 0.83
ROIC/WACC0.63
WACC2.83%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ICAD has a Current Ratio of 1.84. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.84, ICAD belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
ICAD has a Quick Ratio of 1.55. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.55, ICAD belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.55
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.06% over the past year.
The Earnings Per Share has been decreasing by -9.69% on average over the past years.
Looking at the last year, ICAD shows a decrease in Revenue. The Revenue has decreased by -5.13% in the last year.
ICAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.64% yearly.
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%

3.2 Future

The Earnings Per Share is expected to decrease by -0.73% on average over the next years.
The Revenue is expected to decrease by -1.82% on average over the next years.
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.85, the valuation of ICAD can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 90.00% of the companies listed in the same industry.
ICAD is valuated cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 6.40, which indicates a rather cheap valuation of ICAD.
Based on the Price/Forward Earnings ratio, ICAD is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 6.85
Fwd PE 6.4
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

70.00% of the companies in the same industry are more expensive than ICAD, based on the Enterprise Value to EBITDA ratio.
70.00% of the companies in the same industry are more expensive than ICAD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.93
EV/EBITDA 14.95
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.28%, ICAD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.52, ICAD has a dividend in line with its industry peers.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 5.28%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-132.91%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (7/4/2025, 7:00:00 PM)

21.66

-0.3 (-1.37%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)07-23 2025-07-23
Inst Owners72.7%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.65B
Analysts71
Price Target25.92 (19.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.28%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-132.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.48%
PT rev (3m)-9.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.66%
Valuation
Industry RankSector Rank
PE 6.85
Fwd PE 6.4
P/S 1.05
P/FCF 9.93
P/OCF 4.51
P/B 0.38
P/tB 0.39
EV/EBITDA 14.95
EPS(TTM)3.16
EY14.59%
EPS(NY)3.39
Fwd EY15.63%
FCF(TTM)2.18
FCFY10.07%
OCF(TTM)4.81
OCFY22.19%
SpS20.62
BVpS56.72
TBVpS56.26
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.38%
ROCE 2.53%
ROIC 1.77%
ROICexc 1.97%
ROICexgc 1.98%
OM 13.47%
PM (TTM) N/A
GM N/A
FCFM 10.57%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF 28.49
Debt/EBITDA 13.44
Cap/Depr 187.28%
Cap/Sales 12.74%
Interest Coverage 2.79
Cash Conversion 115%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.55
Altman-Z 0.83
F-Score7
WACC2.83%
ROIC/WACC0.63
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A
EBIT growth 1Y-17.53%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year45.89%
EBIT Next 3Y14.53%
EBIT Next 5Y8.67%
FCF growth 1Y4516.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%